Dianthus Therapeutics (DNTH) PT Raised to $92 at Guggenheim
Tweet Send to a Friend
(Updated - July 28, 2025 6:11 AM EDT)
Guggenheim analyst Yatin Suneja raised the price target on Dianthus Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Yatin Suneja raised the price target on Dianthus Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
